Stock Price Forecast

March 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading AMGEN Inc. chart...

About the Company

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the worlds largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.

CEO

Robert Bradway

Exchange

NASDAQ

Website

https://www.amgen.com/

$6B

Total Revenue

25K

Employees

$145B

Market Capitalization

19.80

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $AMGN News

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

13h ago, source: Zacks.com on MSN

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock

12d ago, source: Zacks.com on MSN

Amgen (AMGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of this ...

Relative Strength Alert For Amgen

3d ago, source: Nasdaq

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Friday, shares of Amgen Inc (Symbol: AMGN) entered into oversold territory, hitting an RSI reading of 29.6 ...

Amgen declares $2.25 dividend

12d ago, source: Seeking Alpha

See AMGN Dividend Scorecard, Yield Chart, & Dividend Growth. Amgen Inc. (AMGN) Presents at TD Cowen 44th Annual Health Care Conference (Transcript) Amgen: A Good Dividend Growth Stock For The ...

AMGEN Inc.

5d ago, source: U.S. News & World Report

Picking the best bond ETF can be hard with so many options available. Here's what the experts suggest focusing on. Marijuana ETFs have had it rough lately, but risk-tolerant investors can tap ...

AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD 2024

9d ago, source: Stockhouse

Amgen is committed to unlocking the potential of biology for ... (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, ...

Amgen Inc. (AMGN) Presents at TD Cowen 44th Annual Health Care Conference (Transcript)

13d ago, source: Seeking Alpha

I'm Yaron Werber from the Biotech team, and it's a great pleasure to moderate the fireside chat next with Amgen, first fireside chat for the day, so have very high expectations. With us today is ...

Looking At Amgen's Recent Unusual Options Activity

4d ago, source:

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $230.0 to $285.0 for Amgen over the recent three months. Looking at the volume ...

AMGEN ANNOUNCES 2024 SECOND QUARTER DIVIDEND

13d ago, source: Stockhouse

Amgen is committed to unlocking the potential of biology for ... (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, ...

FDA Approves Sandoz Biosimilars for Two Blockbuster Amgen Bone Drugs

13d ago, source: MedCity News

Sandoz drugs Jubbonti and Xgeva are approved for use in all indications covered by the Amgen products, Prolia and Xgeva. But ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...